Literature DB >> 3900730

Systemic candidiasis in mice immunized with Candida albicans ribosomes.

R Levy, E Segal, L Barr-Nea.   

Abstract

In view of our previous findings that vaccination of mice with Candida albicans ribosomes protects them against experimental systemic candidiasis, the aim of this study was to investigate the effect of this vaccination on the course of infection in immunized animals. Since the kidney is the major target in systemic candidal infection, we concentrated in this research on studying the histopathology and determining quantitatively the candidal colonization of this organ. The experiments were carried out at various time intervals after intravenous inoculation with live C. albicans. The colonization of kidneys in immunized mice was markedly lower than that in controls. The maximal difference in renal colonization between immunized and non immunized animals was observed when relatively low challenge doses were used. The inhibition of candidal multiplication in immunized mice seemed to be correlated to their increased resistance against lethal challenge, as expressed by a significantly higher survival rate. Histopathological changes and fungal elements were found in kidneys of control mice as early as 20 h post infection, while the kidneys of immunized mice did not seem affected by the disease. Moreover, even 3 days post infection, the kidneys of vaccinated animals still seemed normal. In conclusion, apparently the ribosomal vaccination leads to diminished colonization of the major site of infection in candidiasis, thus affording protection to the immunized animals against these infections.

Entities:  

Mesh:

Year:  1985        PMID: 3900730     DOI: 10.1007/bf00437281

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

1.  Experimental renal moniliasis in the mouse.

Authors:  R HURLEY; H I WINNER
Journal:  J Pathol Bacteriol       Date:  1963-07

2.  Organ distribution and viability of Candida albicans in noncancerous and tumor-bearing (Lewis lung carcinoma) mice.

Authors:  D N Mardon; E H Robinette
Journal:  Can J Microbiol       Date:  1978-12       Impact factor: 2.419

Review 3.  Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

Authors:  M S Seelig
Journal:  Bacteriol Rev       Date:  1966-06

4.  Experimental renal candidiasis in mice and guinea pigs.

Authors:  B Winblad
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-07

5.  Protective effect of glucan in experimentally induced candidiasis.

Authors:  D L Williams; J A Cook; E O Hoffmann; N R Di Luzio
Journal:  J Reticuloendothel Soc       Date:  1978-06

6.  Experimental Candida albicans infection in conventional mice and germfree rats.

Authors:  T Rogers; E Balish
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Cell-mediated immunity following experimental vaccinations with Candida albicans ribosomes.

Authors:  R Levy; E Segal; E Eylan; L Barr-Nea
Journal:  Mycopathologia       Date:  1983-11-25       Impact factor: 2.574

8.  Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions.

Authors:  R Levy; E Segal; E Eylan
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Systemic candidiasis in mice. I.--Correlation between kidney infection and mortality rate.

Authors:  B Hurtrel; P H Lagrange; J C Michel
Journal:  Ann Immunol (Paris)       Date:  1980 Jan-Feb

10.  Clearance of Candida albicans from the bloodstream of rabbits.

Authors:  W B Baine; M G Koenig; J S Goodman
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  3 in total

1.  Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.

Authors:  S Mizutani; M Endo; T Ino-Ue; M Kurasawa; Y Uno; H Saito; I Kato; K Takesako
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.

Authors:  S Mizutani; M Endo; T Ino-Ue; M Kurasawa; Y Uno; H Saito; K Onogi; I Kato; K Takesako
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.

Authors:  L Cárdenas-Freytag; E Cheng; P Mayeux; J E Domer; J D Clements
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.